Why does an adult on fluvoxamine 150 mg daily and lamotrigine (Lamictal) 200 mg daily experience mood swings, and how should this be managed?

Fluvoxamine is likely destabilizing mood and should be discontinued or significantly reduced

The most probable cause of mood swings in this patient is fluvoxamine-induced mood destabilization, as SSRIs can precipitate manic episodes or mood instability in patients with underlying bipolar disorder, even when taking a mood stabilizer like lamotrigine. 1

Why This Is Happening

Fluvoxamine's Role in Mood Destabilization

The guidelines explicitly warn that antidepressants may destabilize mood or incite manic episodes in bipolar patients, even when combined with mood stabilizers 1. The evidence states: "Caution must be taken, however, because antidepressants may destabilize the patient's mood or incite a manic episode" and "Manic symptoms associated with an SSRI may represent the unmasking of the disorder or disinhibition secondary to the agent" 1.

Fluvoxamine at 150 mg daily is a substantial dose that carries significant risk for:

• Mood destabilization through serotonergic activation 2
• Unmasking underlying bipolar disorder if not previously diagnosed 1
• Inducing rapid cycling or mixed states 1

Lamotrigine's Limitations

While lamotrigine 200 mg is FDA-approved for maintenance therapy in bipolar disorder 1, it has no antimanic properties and primarily prevents depressive episodes 3, 4. Recent evidence shows lamotrigine itself can paradoxically induce manic episodes in vulnerable populations, particularly in patients with:

• Bipolar I disorder
• Manic predominant polarity
• History of antidepressant-induced switches 5, 6, 7

The combination of an activating SSRI with a mood stabilizer that lacks antimanic efficacy creates a perfect storm for mood instability.

Immediate Management Algorithm

Step 1: Assess Bipolar Disorder Diagnosis

• If bipolar disorder is confirmed or suspected: Fluvoxamine must be tapered and discontinued
• If only unipolar depression: Still consider discontinuation given mood swings, but proceed more cautiously

Step 2: Discontinue or Taper Fluvoxamine

Taper fluvoxamine gradually to avoid discontinuation syndrome, which includes irritability, agitation, anxiety, and mood lability 8, 2. Fluvoxamine is specifically associated with discontinuation syndrome 8.

Suggested taper schedule:

• Reduce by 25-50 mg every 1-2 weeks
• Monitor closely for withdrawal symptoms (dizziness, sensory disturbances, irritability, anxiety)
• If intolerable symptoms emerge, slow the taper further 2

Step 3: Optimize Mood Stabilization

Add an antimanic agent immediately if manic symptoms are present:

• Lithium (FDA-approved for acute mania and maintenance) 1
• Valproate (approved for acute mania in adults) 1
• Atypical antipsychotics (aripiprazole, risperidone, quetiapine, olanzapine) 1

Do not rely on lamotrigine alone for mood stabilization during this period, as it lacks antimanic efficacy 3, 4.

Step 4: Consider Lamotrigine Adjustment

Given emerging evidence of lamotrigine-induced mania 5, 6, 7, evaluate whether lamotrigine itself is contributing to mood instability:

• If patient has bipolar I, manic predominant polarity, or history of antidepressant-induced switches, consider reducing or discontinuing lamotrigine 5
• If continuing lamotrigine, ensure adequate antimanic coverage with another agent

Critical Drug Interaction Warning

Fluvoxamine has extensive CYP450 interactions that may affect lamotrigine metabolism 8. Fluvoxamine inhibits CYP1A2, CYP2C19, CYP2C9, CYP3A4, and CYP2D6 8. While lamotrigine is primarily metabolized by glucuronidation, any co-administered medications metabolized by these pathways require dose adjustment.

Common Pitfalls to Avoid

1. Do not simply increase lamotrigine dose - it lacks antimanic properties and may worsen the situation 5, 3, 4

2. Do not abruptly stop fluvoxamine - this will cause severe discontinuation syndrome with worsening mood symptoms 8, 2

3. Do not add another antidepressant - this will perpetuate the problem 1

4. Do not ignore the possibility of bipolar disorder - SSRIs can unmask previously undiagnosed bipolar disorder 1, 2

Long-term Strategy

For bipolar depression maintenance (if that is the underlying diagnosis):

• Lamotrigine monotherapy (if tolerated and effective) 1
• Lithium or valproate monotherapy 1
• Olanzapine-fluoxetine combination (FDA-approved for bipolar depression) 1
• Atypical antipsychotics with mood-stabilizing properties 1

Avoid SSRI monotherapy or SSRI without adequate mood stabilizer coverage in confirmed bipolar disorder 1.